Method of regulatory network that can explore protein regulations for disease classification.
OBJECTIVE
To develop regulatory network to explore and model the regulatory relationships of protein biomarkers and classify different disease groups.


METHODS
Regulatory network is constructed to be a hopfield-like network with nodes representing biomarkers and directional connections to be regulations in between. The input to the network is the measured expression levels of biomarkers, and the output is the summation of regulatory strengths from other biomarkers. The network is optimized towards minimizing the energy function that is defined as the measure of the disagreement between the input and output of the network. To simulate more complicated regulations, a sigmoid kernel function is imposed on each node to construct a non-linear regulatory network.


RESULTS
Two datasets have been used as test beds, one dataset includes patients of nasopharyngeal carcinoma with different responses to chemotherapy drug, and the other consists of patients of severe acute respiratory syndrome, influenza, and control normals. The regulatory networks among protein biomarkers were reconstructed for different disease conditions in each dataset. We demonstrated our methods have better classification capability when comparing with conventional methods including Fisher linear discriminant (FLD), K-nearest neighborhood (KNN), linear support vector machines (linSVM) and radial basis function based support vector machines (rbfSVM).


CONCLUSIONS
The derived networks can effectively capture the unique regulatory patterns of protein markers associated with different patient groups and hence can be used for disease classification. The discovered regulation relationships can potentially provide insights to revealing the molecular signaling pathways. In this paper, a novel technique of regulatory network is proposed on purpose of modeling biomarker regulations and classifying different disease groups. The network is composed of a certain number of nodes that are directionally connected in between in which nodes denote predictors and connections to be the regulation relationship. The network is optimized towards minimizing its energy function with biomarker expression data acquired from a specific patient group, thus the optimized network can model the regulatory relationship of biomarkers under the same circumstance. To simulate more complicated regulations, a sigmoid kernel function is imposed on each node to construct a non-linear regulatory network. The regulatory network can extract unique features of each disease condition, thus one immediate application of regulatory network is to classifying different diseases. We demonstrated that regulatory network is capable of performing disease classification through comparing with conventional methods including FLD, KNN, linSVM and rbfSVM on two protein datasets. We believe our method is promising in mining knowledge of protein regulations and be powerful for disease classification.
Wang
Hong Qiang
HQ
Research Institute of Innovative Products and Technologies, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong.
Zhu
Hai Long
HL
Cho
William C S
WC
Yip
Timothy T C
TT
Ngan
Roger K C
RK
Law
Stephen C K
SC
D000465:Algorithms; D000970:Antineoplastic Agents / Q000627:therapeutic use; D001185:Artificial Intelligence; D015415:Biomarkers / Q000378:metabolism; D003198:Computer Simulation; D006801:Humans; D007251:Influenza, Human / Q000175:diagnosis / Q000378:metabolism; D008954:Models, Biological; D015233:Models, Statistical; D009303:Nasopharyngeal Neoplasms / Q000175:diagnosis / Q000188:drug therapy / Q000378:metabolism; D016571:Neural Networks, Computer; D017711:Nonlinear Dynamics; D011237:Predictive Value of Tests; D040081:Protein Array Analysis; D011506:Proteins / Q000378:metabolism*; D040901:Proteomics / Q000379:methods*; D045169:Severe Acute Respiratory Syndrome / Q000175:diagnosis / Q000378:metabolism; D015398:Signal Transduction; D049490:Systems Biology; D018511:Systems Integration; D016896:Treatment Outcome
D000970:Antineoplastic Agents; D015415:Biomarkers; D011506:Proteins